My Favorite Biotech

04:00pm, Friday, 13'th May 2022
Here's why three Fool.com contributors love 10x Genomics, Axsome Therapeutics, and Doximity.
If you have a long investing time horizon, these strong performers could deliver massive gains.
These companies strike the right balance of potential and leadership, which could help them achieve strong returns over the next decade.
Doximity's revolutionary business model creates a compelling competitive advantage for the company.
The market has put these stocks on sale.
Is Doximity or Teladoc the better investment right now?

Why Doximity Stock Slumped 15% in March

01:08pm, Tuesday, 05'th Apr 2022
Doximity's high valuation hurt the stock even though it didn't publish any bad news in March.

2 TeleHealth Stocks to Buy, 1 to Watch in 2022

11:23am, Saturday, 02'nd Apr 2022
Patient care via phone and video is far from finished.

3 Best Telemedicine Stocks for Investors

03:00am, Saturday, 02'nd Apr 2022
What's a break in the clouds due to the pandemic? Maybe the ease of meeting with your doctor.
Doximity (DOCS) is a high-quality company which we previously covered. At the time we came to the conclusion shares were too expensive.
OCDX vs. DOCS: Which Stock Is the Better Value Option?
This market provides plenty of opportunities for great deals.

Why Shopify, Doximity, and Datadog Stock Fell Today

07:20pm, Monday, 14'th Mar 2022 The Motley Fool
Investors are anticipating a Federal Reserve rate hike this week.
Investors are anticipating a Federal Reserve rate hike this week.
With prices on many stocks dropping like stones, these two companies are near the top of my "to buy" watchlist.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE